CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 8-K Event Executive or director change
- 8-K Event Results of operations · Other events
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 27,707 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 30,935 shares (to pay taxes)
- 4 Open-market sale Director sold 1,600 shares at an average $364.98 ($583,964)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,104 shares at $365.00 ($1,862,960)
- SD Other Specialized Disclosure
- 4 Open-market buy Director bought 300 shares at $352.55 ($105,765)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Bylaws or fiscal year change
- 4 Option exercise Pres. Diagnostics & Genom acquired 1,989 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President, Protein Sciences acquired 2,490 shares (grant or award)
- 4 Option exercise Chief Executive Officer acquired 1,737 shares (option exercise)
- 8-K Event Results of operations · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 15 of 65 · 1,282 filings